Global In Vitro Diagnostics (IVD) Market: Analysis By Product (Medical Devices, Reagents and Kits, Services), By Technology, Application, End User, By Region, By Country (2019 Edition): Opportunities and Forecast (2014-2024) – By Region (N. America, L. America, Europe, APAC, ROW), By Country (U.S, Canada, Germany, UK, Italy, Japan, China, India, Brazil, Mexico)
EXECUTIVE SUMMARY
Global In Vitro Diagnostics Market was valued at USD 61700.22 Million in the year 2018. As size of old age population is increasing globally, quality healthcare is required. Diagnostics have major role, as majority of clinical decisions are based on diagnostic test result. They assist in providing personalised treatment and drugs are administered to the patient specifically. Additionally, number of patients suffering from chronic and infectious disease are increasing globally, which is primarily powered by unhealthy lifestyle, air and water pollution, genetic modification of disease causing microbes, which is estimated to accelerate the In Vitro Diagnostics Market Growth during the period of 2019-2024.
Molecular Diagnostics technology has been estimated to propel the market growth globally mainly because of large number of chronic diseases such as cancer, genetic disease, Non Invasive Prenatal Testing. Also, End User growth rate of home test kits will be high due to ease of testing, cost effectiveness and accuracy of test results obtained. By product type, reagents and kits will have high growth rate, as they get consumed in the diagnostic process and have to be replenished. Also rising investment by leading IVD companies in development and automation of IVD products, according to disease specificity, has been anticipated to spur the market growth during the forecast period.
SCOPE OF THE REPORT
Global In Vitro Diagnostics Market (Actual Period: 2014-2018, Forecast Period: 2019-2024)
The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.
Global In Vitro Diagnostics Market was valued at USD 61700.22 Million in the year 2018. As size of old age population is increasing globally, quality healthcare is required. Diagnostics have major role, as majority of clinical decisions are based on diagnostic test result. They assist in providing personalised treatment and drugs are administered to the patient specifically. Additionally, number of patients suffering from chronic and infectious disease are increasing globally, which is primarily powered by unhealthy lifestyle, air and water pollution, genetic modification of disease causing microbes, which is estimated to accelerate the In Vitro Diagnostics Market Growth during the period of 2019-2024.
Molecular Diagnostics technology has been estimated to propel the market growth globally mainly because of large number of chronic diseases such as cancer, genetic disease, Non Invasive Prenatal Testing. Also, End User growth rate of home test kits will be high due to ease of testing, cost effectiveness and accuracy of test results obtained. By product type, reagents and kits will have high growth rate, as they get consumed in the diagnostic process and have to be replenished. Also rising investment by leading IVD companies in development and automation of IVD products, according to disease specificity, has been anticipated to spur the market growth during the forecast period.
SCOPE OF THE REPORT
Global In Vitro Diagnostics Market (Actual Period: 2014-2018, Forecast Period: 2019-2024)
- In Vitro Diagnostics Market – Size, Growth, Forecast
- Analysis By Technology: Centralised and Point of care, Diabetes Care, Molecular Diagnostics, Tissue Diagnostics
- Analysis By Application: Infectious Disease, Non Infectious Disease
- Analysis By End User: Hospital, Laboratory, Home Test, Others
- Analysis By Product- Medical Devices, Reagents & Kits, Services
- In Vitro Diagnostics Market – Size, Growth, Forecast
- Analysis By Technology: Centralised and Point of care, Diabetes Care, Molecular Diagnostics, Tissue Diagnostics
- Analysis By Application: Infectious Disease, Non Infectious Disease
- Analysis By End User: Hospital, Laboratory, Home Test, Others
- Analysis By Product- Medical Devices, Reagents & Kits, Services
- In Vitro Diagnostics Market – Size, Growth, Forecast
- Analysis By Technology: Centralised and Point of care, Diabetes Care, Molecular Diagnostics, Tissue Diagnostics
- Analysis By Application: Infectious Disease, Non Infectious Disease
- Analysis By End User: Hospital, Laboratory, Home Test, Others
- Analysis By Product- Medical Devices, Reagents & Kits, Services
- Competitive Landscape
- Leading Companies
- Key Developments
- Market Dynamics – Drivers and Restraints.
- Market Trends
- SWOT Analysis.
- Company Analysis – Roche, Sysmex, Abbott, Danaher, Siemens Healthineers, Biomerieux, Becton-Dickinson, Thermofisher Scientific, Bio-Rad, Ortho clinical Diagnostics.
The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.
1. REPORT SCOPE & METHODOLOGY
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary
2. STRATEGIC RECOMMENDATIONS
2.1 Focus on Theranostics
2.2 Investment in Microbiology system automation
2.3 Reducing the cost of diagnostic test
3. GLOBAL IVD MARKET: PRODUCT OUTLOOK
4. GLOBAL IN VITRO DIAGNOSTICS MARKET: AN ANALYSIS
4.1 Market Size, By Value, Year 2014-2024
5. GLOBAL IN VITRO DIAGNOSTICS SEGMENTATION BY TECHNOLOGY (BY VALUE)
5.1 Competitive Scenario of In Vitro Diagnostics: By Technology
5.2 Centralised and Point of Care – Market Size and Forecast (2019-2024)
5.3 Diabetes Care - Market Size and Forecast (2019-2024)
5.4 Molecular Diagnostics - Market Size and Forecast (2019-2024)
5.5 Tissue Diagnostics - Market Size and Forecast (2019-2024)
6. GLOBAL IN VITRO DIAGNOSTICS MARKET SEGMENTATION BY APPLICATION (BY VALUE)
6.1 Competitive Scenario of Global In Vitro Diagnostics: By Application
6.2 Infectious Disease – Market Size and Forecast (2019-2024)
6.3 Non Infectious Disease- Market Size and Forecast (2019-2024)
7.GLOBAL IN VITRO DIAGNOSTICS SEGMENTATION BY END USER (BY VALUE)
7.1 Competitive Scenario of Global In Vitro Diagnostics: By End User
7.2 Hospitals – Market Size and Forecast (2019-2024)
7.3 Laboratory - Market Size and Forecast (2019-2024)
7.4 Home Test - Market Size and Forecast (2019-2024)
7.5 Others - Market Size and Forecast (2019-2024
8. GLOBAL IN VITRO DIAGNOSTICS SEGMENTATION BY PRODUCTS (BY VALUE)
8.1 Competitive Scenario of Global In Vitro Diagnostics: By Products
8.2 Medical Devices – Market Size and Forecast (2019-2024)
8.3 Reagents and Kits – Market Size and Forecast (2019-2024)
8.4 Services – Market Size and Forecast (2019-2024)
9. GLOBAL IN VITRO DIAGNOSTICS: REGIONAL ANALYSIS
9.1 Competitive Scenario of Global In Vitro Diagnostics: By Region
10. NORTH AMERICA IN VITRO DIAGNOSTICS MARKET: SEGMENTATION BY TECHNOLOGY, APPLICATION, END USER, PRODUCTS (2019-2024)
10.1 North America In Vitro Diagnostics Market: Size and Forecast (2019-2024)
10.2 North America In Vitro Diagnostics Market – Prominent Companies
10.3 Market Segmentation By Technology (Centralised & POC, Diabetes Care, Molecular Diagnostics, Tissue Diagnostics)
10.4 Market Segmentation By Application (Infectious Disease, Non Infectious Disease)
10.5 Market Segmentation By End User (Hospitals, Laboratory, Home Test, Others)
10.6 Market Segmentation By Products (Medical Devices, Reagents and Kits, Services)
10.7 North America In Vitro Diagnostics Market: Country Analysis
10.8 Market Opportunity Chart of North America In Vitro Diagnostics Market- By Country, By Value (Year-2024)
10.9 Competitive Scenario of North America In Vitro Diagnostics : By Country
10.10 United States In Vitro Diagnostics Market: Size and Forecast (2019-2024)
10.11 United States In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
10.12 Canada In Vitro Diagnostics Market: Size and Forecast (2019-2024)
10.13 Canada In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
10.14 Rest of North America In Vitro Diagnostics Market: Size and Forecast (2019-2024)
10.15 Rest of North America In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
11. LATIN AMERICA IN VITRO DIAGNOSTICS MARKET: SEGMENTATION BY TECHNOLOGY, APPLICATION, END USER, PRODUCTS (2019-2024)
11.1 Latin America In Vitro Diagnostics Market: Size and Forecast (2019-2024)
11.2 Latin America In Vitro Diagnostics Market – Prominent Companies
11.3 Market Segmentation By Technology (Centralised & POC, Diabetes Care, Molecular Diagnostics, Tissue Diagnostics)
11.4 Market Segmentation By Application (Infectious Disease, Non Infectious Disease)
11.5 Market Segmentation By End User (Hospitals, Laboratory, Home Test, Others)
11.6 Market Segmentation By Products (Medical Devices, Reagents and Kits, Services)
11.7 Latin America In Vitro Diagnostics Market: Country Analysis
11.8 Market Opportunity Chart of Latin America In Vitro Diagnostics Market- By Country, By Value (Year-2024)
11.9 Competitive Scenario of Latin America In Vitro Diagnostics: By Country
11.10 Brazil In Vitro Diagnostics Market: Size and Forecast (2019-2024)
11.11 Brazil In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
11.12 Mexico In Vitro Diagnostics Market: Size and Forecast (2019-2024)
11.13 Mexico In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
11.14 Rest of Latin America In Vitro Diagnostics Market: Size and Forecast (2019-2024)
11.15 Rest of Latin America In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
12.ASIA PACIFIC IN VITRO DIAGNOSTICS MARKET: SEGMENTATION BY TECHNOLOGY, APPLICATION, END USER, PRODUCTS (2019-2024)
12.1 Asia Pacific In Vitro Diagnostics Market: Size and Forecast (2019-2024)
12.2 Asia Pacific In Vitro Diagnostics Market – Prominent Companies
12.3 Market Segmentation By Technology (Centralised & POC, Diabetes Care, Molecular Diagnostics, Tissue Diagnostics)
12.4 Market Segmentation By Application (Infectious Disease, Non Infectious Disease)
12.5 Market Segmentation By End User (Hospitals, Laboratory, Home Test, Others)
12.6 Market Segmentation By Products (Medical Devices, Reagents and Kits, Services)
12.7 Asia Pacific In Vitro Diagnostics Market: Country Analysis
12.8 Market Opportunity Chart of Asia Pacific In Vitro Diagnostics Market- By Country, By Value (Year-2024)
12.9 Competitive Scenario of Asia Pacific In Vitro Diagnostics : By Country
12.10 Japan In Vitro Diagnostics Market: Size and Forecast (2019-2024)
12.11 Japan In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
12.12 China In Vitro Diagnostics Market: Size and Forecast (2019-2024)
12.13 China In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
12.14 India In Vitro Diagnostics Market: Size and Forecast (2019-2024)
12.15 India In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
12.16 Rest of Asia Pacific In Vitro Diagnostics Market: Size and Forecast (2019-2024)
12.17 Rest of Asia Pacific In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
13. EMEA IN VITRO DIAGNOSTICS MARKET: SEGMENTATION BY TECHNOLOGY, APPLICATION, END USER, PRODUCTS (2019-2024)
13.1 EMEA In Vitro Diagnostics Market: Size and Forecast (2019-2024)
13.2 EMEA In Vitro Diagnostics Market – Prominent Companies
13.3 Market Segmentation By Technology (Centralised & POC, Diabetes Care, Molecular Diagnostics, Tissue Diagnostics)
13.4 Market Segmentation By Application (Infectious Disease, Non Infectious Disease)
13.5 Market Segmentation By End User (Hospitals, Laboratory, Home Test, Others)
13.6 Market Segmentation By Products (Medical Devices, Reagents and Kits, Services)
13.7 EMEA In Vitro Diagnostics Market: Country Analysis
13.8 Market Opportunity Chart of EMEA In Vitro Diagnostics Market- By Country, By Value (Year-2024)
13.9 Competitive Scenario of EMEA In Vitro Diagnostics : By Country
13.10 Germany In Vitro Diagnostics Market: Size and Forecast (2019-2024)
13.11 Germany In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
13.12 Italy In Vitro Diagnostics Market: Size and Forecast (2019-2024)
13.13 Italy In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
13.14 United Kingdom In Vitro Diagnostics Market: Size and Forecast (2019-2024)
13.15 United Kingdom In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
13.14 Rest of EMEA In Vitro Diagnostics Market: Size and Forecast (2019-2024)
13.15 Rest of EMEA In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
14. GLOBAL IN VITRO DIAGNOSTICS MARKET DYNAMICS
14.1 Global In Vitro diagnostic Market Drivers
14.2 Global In Vitro Diagnostic Market Restraints
14.3 Global In Vitro Diagnostic Market Trends
15. MARKET ATTRACTIVENESS AND STRATEGIC ANALYSIS
15.1 Market Attractiveness
15.1.1 Market Attractiveness Chart of Global In Vitro Diagnostics Market - By Technology (Year 2024)
15.1.2 Market Attractiveness Chart of Global In Vitro Diagnostics Market – By Application (Year 2024)
15.1.3 Market Attractiveness Chart of Global In Vitro Diagnostics Market – By End User (Year 2024)
15.1.4 Market Attractiveness Chart of Global In Vitro Diagnostics Market – By Products (Year 2024)
15.1.5 Market Attractiveness Chart of Global In Vitro Diagnostics Market – By Region (Year 2024)
15.2 Strategic Analysis
15.2.1 New Product Development
15.2.2 Key Developments in In Vitro Diagnostics Market
16. COMPETITIVE LANDSCAPE
16.1 Market Share Analysis
16.2 Competitive Positioning (Leaders, Challengers, Followers, Niche Players)
16.3 SWOT Analysis
16.4 Porter’s Five Force Analysis
17. COMPANY ANALYSIS (BUSINESS DESCRIPTION, FINANCIAL ANALYSIS, BUSINESS STRATEGY)
17.1 F .Hoffman-La Roche AG
17.2 Thermo Fisher Scientific
17.3 Sysmex
17.4 Abbott
17.5 Danaher
17.6 Siemens Healthineers
17.7 Biomerieux
17.8 Bio- Rad Laboratories
17.9 Becton Dickinson
17.10 Ortho Clinical Diagnostics
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary
2. STRATEGIC RECOMMENDATIONS
2.1 Focus on Theranostics
2.2 Investment in Microbiology system automation
2.3 Reducing the cost of diagnostic test
3. GLOBAL IVD MARKET: PRODUCT OUTLOOK
4. GLOBAL IN VITRO DIAGNOSTICS MARKET: AN ANALYSIS
4.1 Market Size, By Value, Year 2014-2024
5. GLOBAL IN VITRO DIAGNOSTICS SEGMENTATION BY TECHNOLOGY (BY VALUE)
5.1 Competitive Scenario of In Vitro Diagnostics: By Technology
5.2 Centralised and Point of Care – Market Size and Forecast (2019-2024)
5.3 Diabetes Care - Market Size and Forecast (2019-2024)
5.4 Molecular Diagnostics - Market Size and Forecast (2019-2024)
5.5 Tissue Diagnostics - Market Size and Forecast (2019-2024)
6. GLOBAL IN VITRO DIAGNOSTICS MARKET SEGMENTATION BY APPLICATION (BY VALUE)
6.1 Competitive Scenario of Global In Vitro Diagnostics: By Application
6.2 Infectious Disease – Market Size and Forecast (2019-2024)
6.3 Non Infectious Disease- Market Size and Forecast (2019-2024)
7.GLOBAL IN VITRO DIAGNOSTICS SEGMENTATION BY END USER (BY VALUE)
7.1 Competitive Scenario of Global In Vitro Diagnostics: By End User
7.2 Hospitals – Market Size and Forecast (2019-2024)
7.3 Laboratory - Market Size and Forecast (2019-2024)
7.4 Home Test - Market Size and Forecast (2019-2024)
7.5 Others - Market Size and Forecast (2019-2024
8. GLOBAL IN VITRO DIAGNOSTICS SEGMENTATION BY PRODUCTS (BY VALUE)
8.1 Competitive Scenario of Global In Vitro Diagnostics: By Products
8.2 Medical Devices – Market Size and Forecast (2019-2024)
8.3 Reagents and Kits – Market Size and Forecast (2019-2024)
8.4 Services – Market Size and Forecast (2019-2024)
9. GLOBAL IN VITRO DIAGNOSTICS: REGIONAL ANALYSIS
9.1 Competitive Scenario of Global In Vitro Diagnostics: By Region
10. NORTH AMERICA IN VITRO DIAGNOSTICS MARKET: SEGMENTATION BY TECHNOLOGY, APPLICATION, END USER, PRODUCTS (2019-2024)
10.1 North America In Vitro Diagnostics Market: Size and Forecast (2019-2024)
10.2 North America In Vitro Diagnostics Market – Prominent Companies
10.3 Market Segmentation By Technology (Centralised & POC, Diabetes Care, Molecular Diagnostics, Tissue Diagnostics)
10.4 Market Segmentation By Application (Infectious Disease, Non Infectious Disease)
10.5 Market Segmentation By End User (Hospitals, Laboratory, Home Test, Others)
10.6 Market Segmentation By Products (Medical Devices, Reagents and Kits, Services)
10.7 North America In Vitro Diagnostics Market: Country Analysis
10.8 Market Opportunity Chart of North America In Vitro Diagnostics Market- By Country, By Value (Year-2024)
10.9 Competitive Scenario of North America In Vitro Diagnostics : By Country
10.10 United States In Vitro Diagnostics Market: Size and Forecast (2019-2024)
10.11 United States In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
10.12 Canada In Vitro Diagnostics Market: Size and Forecast (2019-2024)
10.13 Canada In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
10.14 Rest of North America In Vitro Diagnostics Market: Size and Forecast (2019-2024)
10.15 Rest of North America In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
11. LATIN AMERICA IN VITRO DIAGNOSTICS MARKET: SEGMENTATION BY TECHNOLOGY, APPLICATION, END USER, PRODUCTS (2019-2024)
11.1 Latin America In Vitro Diagnostics Market: Size and Forecast (2019-2024)
11.2 Latin America In Vitro Diagnostics Market – Prominent Companies
11.3 Market Segmentation By Technology (Centralised & POC, Diabetes Care, Molecular Diagnostics, Tissue Diagnostics)
11.4 Market Segmentation By Application (Infectious Disease, Non Infectious Disease)
11.5 Market Segmentation By End User (Hospitals, Laboratory, Home Test, Others)
11.6 Market Segmentation By Products (Medical Devices, Reagents and Kits, Services)
11.7 Latin America In Vitro Diagnostics Market: Country Analysis
11.8 Market Opportunity Chart of Latin America In Vitro Diagnostics Market- By Country, By Value (Year-2024)
11.9 Competitive Scenario of Latin America In Vitro Diagnostics: By Country
11.10 Brazil In Vitro Diagnostics Market: Size and Forecast (2019-2024)
11.11 Brazil In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
11.12 Mexico In Vitro Diagnostics Market: Size and Forecast (2019-2024)
11.13 Mexico In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
11.14 Rest of Latin America In Vitro Diagnostics Market: Size and Forecast (2019-2024)
11.15 Rest of Latin America In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
12.ASIA PACIFIC IN VITRO DIAGNOSTICS MARKET: SEGMENTATION BY TECHNOLOGY, APPLICATION, END USER, PRODUCTS (2019-2024)
12.1 Asia Pacific In Vitro Diagnostics Market: Size and Forecast (2019-2024)
12.2 Asia Pacific In Vitro Diagnostics Market – Prominent Companies
12.3 Market Segmentation By Technology (Centralised & POC, Diabetes Care, Molecular Diagnostics, Tissue Diagnostics)
12.4 Market Segmentation By Application (Infectious Disease, Non Infectious Disease)
12.5 Market Segmentation By End User (Hospitals, Laboratory, Home Test, Others)
12.6 Market Segmentation By Products (Medical Devices, Reagents and Kits, Services)
12.7 Asia Pacific In Vitro Diagnostics Market: Country Analysis
12.8 Market Opportunity Chart of Asia Pacific In Vitro Diagnostics Market- By Country, By Value (Year-2024)
12.9 Competitive Scenario of Asia Pacific In Vitro Diagnostics : By Country
12.10 Japan In Vitro Diagnostics Market: Size and Forecast (2019-2024)
12.11 Japan In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
12.12 China In Vitro Diagnostics Market: Size and Forecast (2019-2024)
12.13 China In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
12.14 India In Vitro Diagnostics Market: Size and Forecast (2019-2024)
12.15 India In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
12.16 Rest of Asia Pacific In Vitro Diagnostics Market: Size and Forecast (2019-2024)
12.17 Rest of Asia Pacific In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
13. EMEA IN VITRO DIAGNOSTICS MARKET: SEGMENTATION BY TECHNOLOGY, APPLICATION, END USER, PRODUCTS (2019-2024)
13.1 EMEA In Vitro Diagnostics Market: Size and Forecast (2019-2024)
13.2 EMEA In Vitro Diagnostics Market – Prominent Companies
13.3 Market Segmentation By Technology (Centralised & POC, Diabetes Care, Molecular Diagnostics, Tissue Diagnostics)
13.4 Market Segmentation By Application (Infectious Disease, Non Infectious Disease)
13.5 Market Segmentation By End User (Hospitals, Laboratory, Home Test, Others)
13.6 Market Segmentation By Products (Medical Devices, Reagents and Kits, Services)
13.7 EMEA In Vitro Diagnostics Market: Country Analysis
13.8 Market Opportunity Chart of EMEA In Vitro Diagnostics Market- By Country, By Value (Year-2024)
13.9 Competitive Scenario of EMEA In Vitro Diagnostics : By Country
13.10 Germany In Vitro Diagnostics Market: Size and Forecast (2019-2024)
13.11 Germany In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
13.12 Italy In Vitro Diagnostics Market: Size and Forecast (2019-2024)
13.13 Italy In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
13.14 United Kingdom In Vitro Diagnostics Market: Size and Forecast (2019-2024)
13.15 United Kingdom In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
13.14 Rest of EMEA In Vitro Diagnostics Market: Size and Forecast (2019-2024)
13.15 Rest of EMEA In Vitro Diagnostics Market Segmentation By Technology, Application, End User, Products (2019-2024)
14. GLOBAL IN VITRO DIAGNOSTICS MARKET DYNAMICS
14.1 Global In Vitro diagnostic Market Drivers
14.2 Global In Vitro Diagnostic Market Restraints
14.3 Global In Vitro Diagnostic Market Trends
15. MARKET ATTRACTIVENESS AND STRATEGIC ANALYSIS
15.1 Market Attractiveness
15.1.1 Market Attractiveness Chart of Global In Vitro Diagnostics Market - By Technology (Year 2024)
15.1.2 Market Attractiveness Chart of Global In Vitro Diagnostics Market – By Application (Year 2024)
15.1.3 Market Attractiveness Chart of Global In Vitro Diagnostics Market – By End User (Year 2024)
15.1.4 Market Attractiveness Chart of Global In Vitro Diagnostics Market – By Products (Year 2024)
15.1.5 Market Attractiveness Chart of Global In Vitro Diagnostics Market – By Region (Year 2024)
15.2 Strategic Analysis
15.2.1 New Product Development
15.2.2 Key Developments in In Vitro Diagnostics Market
16. COMPETITIVE LANDSCAPE
16.1 Market Share Analysis
16.2 Competitive Positioning (Leaders, Challengers, Followers, Niche Players)
16.3 SWOT Analysis
16.4 Porter’s Five Force Analysis
17. COMPANY ANALYSIS (BUSINESS DESCRIPTION, FINANCIAL ANALYSIS, BUSINESS STRATEGY)
17.1 F .Hoffman-La Roche AG
17.2 Thermo Fisher Scientific
17.3 Sysmex
17.4 Abbott
17.5 Danaher
17.6 Siemens Healthineers
17.7 Biomerieux
17.8 Bio- Rad Laboratories
17.9 Becton Dickinson
17.10 Ortho Clinical Diagnostics
LIST OF FIGURES
Figure 1: Global In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 2: Life expectancy above 65 years of age, year-2017
Figure 3: Deaths due to communicable, Maternal, Neonatal disorders and Nutritional Deficiencies(%), Year-2017
Figure 4: Global, Diabetics Incidence Rates, 2013-2017, Per 100000
Figure 5: Global Market share By technology 2018 & 2024
Figure 6: Global In Vitro Diagnostics Market- By Centralised and point of care, By Value (USD Million), 2014-2024
Figure 7: Global In Vitro Diagnostics Market- By Diabetes Care, By Value (USD Million), 2014-2024
Figure 8: Global In Vitro Diagnostics Market- By Molecular Diagnostics, By Value (USD Million), 2014-2024
Figure 9: Global In Vitro Diagnostics Market- By Tissue Diagnostics, By Value (USD Million), 2014-2024
Figure 10: Global Market Share by Application 2018 & 2024
Figure 11: Global In Vitro Diagnostics Market- By Non Infectious Disease, By Value (USD Million), 2014-2024
Figure 12: Global In Vitro Diagnostics Market- By Infectious Disease, By Value (USD Million), 2014-2024
Figure 13: Global Market Share By End User 2018 & 2024
Figure 14: Global In Vitro Diagnostics Market- By Hospitals, By Value (USD Million), 2014-2024
Figure 15: Global In Vitro Diagnostics Market- By Laboratory, By Value (USD Million), 2014-2024
Figure 16: Global In Vitro Diagnostics Market- By Home Test, By Value (USD Million), 2014-2024
Figure 17: Global In Vitro Diagnostics Market- By Others, By Value (USD Million), 2014-2024
Figure 18: Global Market Share By Products 2018 & 2024
Figure 19: Global In Vitro Diagnostics Market- By Medical Devices, By Value (USD Million), 2014-2024
Figure 20: Global In Vitro Diagnostics Market- By Reagents and Kits, By Value (USD Million), 2014-2024
Figure 21: Global In Vitro Diagnostics Market- By Services, By Value (USD Million), 2014-2024
Figure 22: Global Market Share by Region 2018 & 2024
Figure 23: North America in Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 24: North America population aged 65 and above, 2013-2016 (% of total)
Figure 25: North America GDP per Capita, 2014-2017 (USD)
Figure 26: North America Healthcare Cost Per Capita, 2018 (USD)
Figure 27: North America Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
Figure 28: North America In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 29: North America In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 30: North America In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 31: North America In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 32: Market Opportunity Chart of North America In Vitro Diagnostics Market - By Country, By Value (Year-2024)
Figure 33: North America IVD, By Country, Year 2018 & 2024
Figure 34: United States In vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 35: United States population aged 65 and above, 2014- 2018(% of total)
Figure 36: United States GDP per Capita, 2013-2017 (USD) (In Trillion)
Figure 37: United States Healthcare Cost Per Capita, 2013-2017(USD)
Figure 38: United States Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
Figure 39: United States In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 40: Uniited States In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 41: United States In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 42: United States In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 43: Canada In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 44: Canada population aged 65 and above, 2014-2018 (% of total)
Figure 45: Canada GDP , 2013-2017 (USD) (In Trillion)
Figure 46: Canada Healthcare Cost Per Capita, 2013-2017 (%)
Figure 47: Canada Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
Figure 48: Canada In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 49: Canada In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 50: Canada In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 51: Canada In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 52: Rest of North America In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 53: Rest of North America In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 54: Rest of North America In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 55: Rest of North America In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 56: Rest of North America In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 57: Latin America in Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 58: Latin America population aged 65 and above, 2013-2018 (% of total)
Figure 59: Latin America GDP, 2013-2017 (USD)(In Trillion)
Figure 60: Latin America Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
Figure 61: Latin America In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 62: Latin America In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 63: Latin America In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 64: Latin America In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 65: Market Opportunity Chart of Latin America In Vitro Diagnostics Market - By Country, By Value (Year-2024)
Figure 66: Latin America IVD, By Country, Year 2018 & 2024
Figure 67: Brazil In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 68: Brazil population aged 65 and above, 2014-2018(%of total)
Figure 69: Brazil GDP , 2013-2017 (USD) (In Trillion)
Figure 70: Brazil Healthcare Cost Per Capita, 2013-2016(%)(Expected)
Figure 71: Brazil Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
Figure 72: Brazil In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 73: Brazil In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 74: Brazil In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 75: Brazil In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 76: Mexico In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 77: Mexico population aged 65 and above, 2014-2018 (% of total)
Figure 78: Mexico GDP , 2013-2017 (USD) (In Trillion)
Figure 79: Mexico Healthcare Cost Per Capita, 2013-2017 (%)
Figure 80: Mexico Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
Figure 81: Mexico In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 82: Mexico In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 83: Mexico In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 84: Mexico In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 85: Rest of Latin America In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 86: Rest of Latin America In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 87: Rest of Latin America In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 88: Rest of Latin America In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 89: Rest of Latin America In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 90: Asia Pacific in Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 91: Asia Pacific population aged 65 and above, 2014-2018 (% of total)
Figure 92: East Asia & Pacific GDP , 2013-2017 (USD) (In Trillion)
Figure 93: Asia Pacific Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
Figure 94: Asia Pacific In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 95: Asia Pacific In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 96: Asia Pacific In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 97: Asia Pacific In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 98: Market Opportunity Chart of Asia Pacific In Vitro Diagnostics Market - By Country, By Value (Year-2024)
Figure 99: Asia Pacific IVD, By Country, Year 2018 & 2024
Figure 100: Japan In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 101: Japan population aged 65 and above, 2014-2018 (% of total)
Figure 102: Japan GDP , 2013-2017 (USD) (In Trillion)
Figure 103: Japan Healthcare Cost Per Capita, 2013-2017 (%)
Figure 104: Japan Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
Figure 105: Japan In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 106: Japan In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 107: Japan In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 108: Japan In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 109: China In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 110: China population aged 65 and above, 2014-2018 (% of total)
Figure 111: China GDP, 2013-2017 (USD) (In Trillion)
Figure 112: China Healthcare Cost Per Capita, 2013-2016 (%)
Figure 113: China Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
Figure 114: China In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 115: China In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 116: China In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 117: China In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 118: India In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 119: India population aged 65 and above, 2014-2018 (% of total)
Figure 120: India GDP, 2013-2017 (USD) (In Trillion)
Figure 121: India Healthcare Cost Per Capita, 2013-2016 (%)
Figure 122: India Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
Figure 123: India In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 124: India In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 125: India In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 126: India In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 127: Rest of Asia Pacific In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 128: Rest of Asia Pacific In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 129: Rest of Asia Pacific In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 130: Rest of Asia Pacific In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 131: Rest of Asia Pacific In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 132: Europe, Middle East and Africa in Vitro Diagnostics Market Size, By Value, 2014-2024 (USD
Figure 133: European Union and North Africa Middle East population aged 65 and above, 2014-2018 (% of total)
Figure 134: European Union and North Africa Middle East,GDP , 2013-2017 (USD) (In Trillion)
Figure 135: European Union and North Africa Middle East, Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
Figure 136: EMEA In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 137: EMEA In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 138: EMEA In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 139: EMEA In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 140: Market Opportunity Chart of EMEA In Vitro Diagnostics Market - By Country, By Value (Year-2024)
Figure 141: EMEA IVD, By Country, Year 2018 & 2024
Figure 142: Germany In Vitro Diagnostic Market Size By value,2014-2024(USD Million)
Figure 143: Germany population aged 65 and above,2014-2018(% of total)
Figure 144: Germany GDP,2013-2017(USD) (In Trillion)
Figure 145: Germany Healthcare cost per capita,2014-2018(%)
Figure 146: Germany death by liver cancer, 2014-2017(per 100k individuals)
Figure 147: Germany In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 148: Germany In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 149: Germany In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 150: Germany In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 151: Italy In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 152: Italy population aged 65 and above, 2014-2018 (% of total)
Figure 153: Italy GDP, 2013-2017 (USD) (In Trillion)
Figure 154: Italy Healthcare Cost Per Capita, 2014-2018 (%)
Figure 155: Italy Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
Figure 156: Italy In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 157: Italy In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 158: Italy In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 159: Italy In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 160: UK In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 161: UK population aged 65 and above, 2014-2018 (% of total)
Figure 162: UK GDP, 2013-2017 (USD) (In Trillion)
Figure 163: UK Healthcare Cost Per Capita, 2014-2018 (%)
Figure 164: UK Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
Figure 165: United Kingdom In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 166: UK In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 167: UK In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 168: UK In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 169: Rest of EMEA In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 170: Rest of EMEA In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 171: Rest of EMEA In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 172: Rest of EMEA In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 173: Rest of EMEA In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 174: Market Attractiveness Chart of Global In Vitro Diagnostics Market - By Technology (Year-2024)
Figure 175: Market Attractiveness Chart of Global In Vitro Diagnostics Market - By Application (Year-2024)
Figure 176: Market Attractiveness Chart of Global In Vitro Diagnostics Market - By End User(Year-2024)
Figure 177: Market Attractiveness Chart of Global In Vitro Diagnostics Market - By Products (Year-2024)
Figure 178: Market Attractiveness Chart of Global In Vitro Diagnostics Market - By Region (Year-2024)
Figure 179: Competitive Positions of In Vitro Diagnostics Companies (2018)
Figure 180: F.Hoffman-La Roche, Diagnostics Sales Revenue, 2014-2018 (USD Million)
Figure 181: F.Hoffman-La Roche, Sales Revenue, By Region, In 2018 (%)
Figure 182: F.Hoffman-La Roche Net Income, Year 2014-2018 (USD MILLION)
Figure 183: F.Hoffman-La Roche, Diagnostics Division Business Area Sales Revenue, 2018 ,(USD Million)
Figure 184: F.Hoffman-La Roche , E7 Leading Emerging Market Sales Revenue, By Region, In 2018 (%)
Figure 185: Thermo Fisher Scientific, Sales Revenue, 2014-2018 (USD Million)
Figure 186: Thermo Fisher Scientific, Net Income, 2014-2018 (USD Million)
Figure 187: Thermo Fisher Scientific, Sales Revenue, By Business Segment, In 2018 (%)
Figure 188: Thermo Fisher Scientific, Sales Revenue, By Geographical Segment, In 2018 (%)
Figure 189: Sysmex, Sales Revenue, 2014-15 to 2018-2019 (USD Million)
Figure 190: Sysmex, Net Income, 2014-2018 (USD Million)
Figure 191: Sysmex, Sales Revenue, By Geographical Segment, In 2018 (%)
Figure 192: Abbott, Total Sales Revenue, 2014-2018 (USD Million)
Figure 193: Abbott, Net Income, 2014-2018 (USD Million)
Figure 194: Abbott, Sales Revenue, By Geographical Segment, In 2018 (%)
Figure 195: Abbott, Diagnostics Sales Revenue, 2014-2018 (USD Million)
Figure 196: Abbott, Diagnostics specific Business Division Sales Revenue, , In 2018 (USD Million)
Figure 197: Danaher, Total Sales Revenue, 2014-2018 (USD Million)
Figure 198: Danaher, Net Income, 2014-2018 (USD Million)
Figure 199: Danaher, Total Sales ,By Business Segments,2018 (USD Million)
Figure 200: Danaher, Sales Revenue ,Diagnostics Segment, By Geographical Segment, In 2018 (%)
Figure 201: Siemens Healthineers , Total Sales Revenue, 2017-2018 (USD Million)
Figure 202: Siemens Healthineers, Net Income, 2017-2018 (USD Million)
Figure 203: Siemens Healthineers Sales Revenue , By Geographical Segment, In 2018 (%)
Figure 204: Siemens Healthineers , Sales Revenue, By Segments,2018 (USD Million)
Figure 205: Siemens Healthineers Revenue By Segment, In 2018 (%) (in Billion)
Figure 206: Biomerieux , Total Sales Revenue, 2014-2018 (USD Million)
Figure 207: Biomerieux, Net Income, 2014-2018 (USD Million)
Figure 208: Biomerieux Sales Revenue , By Geographical Segment, In 2018 (%)
Figure 209: Biomerieux , Sales By Application, 2018 (%)
Figure 210: Bio-Rad Laboratories Sales Revenue, 2014-2018 (USD Million)
Figure 211: Bio-Rad Laboratories ,Business Segment wise sales FY- 2016-2018 ,(USD millions)
Figure 212: Bio-Rad Laboratories Sales Revenue, By Geographic Segment (%), FY2018
Figure 213: Bio-Rad, Net Income, 2014-2018 (USD Million)
Figure 214: Becton Dickinson Sales Revenue, 2013-2014 to 2017-2018 (USD Million)
Figure 215: Becton Dickinson , Total Business Segment Revenue FY- 2018 ,(USD millions)
Figure 216: Becton Dickinson Geographic Sales Revenue,2018 (USD Million)
Figure 217: Becton Dickinson, Net Income, 2014-2018 (USD Million)
Figure 218: Becton Dickinson, Life Sciences Business Segment Revenue 2018 ,(USD millions)
List Of Table
Table A: 12. List of some FDA approved In Vitro Diagnostic Products
Table B: General IVDs for use in community settings and health facilities without laboratories
Table C: Health care facilities with clinical laboratories
Table D: Prominent In Vitro Diagnostics companies operating in North America Market
Table E: Prominent In Vitro Diagnostics companies operating in Latin America Market
Table F: Prominent In Vitro Diagnostics companies operating in Asia Pacific Market
Table G: Prominent In Vitro Diagnostics companies operating in EMEA Market
Table H: GlobalMarket share analysis of In Vitro Dignostic Companies
Figure 1: Global In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 2: Life expectancy above 65 years of age, year-2017
Figure 3: Deaths due to communicable, Maternal, Neonatal disorders and Nutritional Deficiencies(%), Year-2017
Figure 4: Global, Diabetics Incidence Rates, 2013-2017, Per 100000
Figure 5: Global Market share By technology 2018 & 2024
Figure 6: Global In Vitro Diagnostics Market- By Centralised and point of care, By Value (USD Million), 2014-2024
Figure 7: Global In Vitro Diagnostics Market- By Diabetes Care, By Value (USD Million), 2014-2024
Figure 8: Global In Vitro Diagnostics Market- By Molecular Diagnostics, By Value (USD Million), 2014-2024
Figure 9: Global In Vitro Diagnostics Market- By Tissue Diagnostics, By Value (USD Million), 2014-2024
Figure 10: Global Market Share by Application 2018 & 2024
Figure 11: Global In Vitro Diagnostics Market- By Non Infectious Disease, By Value (USD Million), 2014-2024
Figure 12: Global In Vitro Diagnostics Market- By Infectious Disease, By Value (USD Million), 2014-2024
Figure 13: Global Market Share By End User 2018 & 2024
Figure 14: Global In Vitro Diagnostics Market- By Hospitals, By Value (USD Million), 2014-2024
Figure 15: Global In Vitro Diagnostics Market- By Laboratory, By Value (USD Million), 2014-2024
Figure 16: Global In Vitro Diagnostics Market- By Home Test, By Value (USD Million), 2014-2024
Figure 17: Global In Vitro Diagnostics Market- By Others, By Value (USD Million), 2014-2024
Figure 18: Global Market Share By Products 2018 & 2024
Figure 19: Global In Vitro Diagnostics Market- By Medical Devices, By Value (USD Million), 2014-2024
Figure 20: Global In Vitro Diagnostics Market- By Reagents and Kits, By Value (USD Million), 2014-2024
Figure 21: Global In Vitro Diagnostics Market- By Services, By Value (USD Million), 2014-2024
Figure 22: Global Market Share by Region 2018 & 2024
Figure 23: North America in Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 24: North America population aged 65 and above, 2013-2016 (% of total)
Figure 25: North America GDP per Capita, 2014-2017 (USD)
Figure 26: North America Healthcare Cost Per Capita, 2018 (USD)
Figure 27: North America Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
Figure 28: North America In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 29: North America In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 30: North America In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 31: North America In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 32: Market Opportunity Chart of North America In Vitro Diagnostics Market - By Country, By Value (Year-2024)
Figure 33: North America IVD, By Country, Year 2018 & 2024
Figure 34: United States In vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 35: United States population aged 65 and above, 2014- 2018(% of total)
Figure 36: United States GDP per Capita, 2013-2017 (USD) (In Trillion)
Figure 37: United States Healthcare Cost Per Capita, 2013-2017(USD)
Figure 38: United States Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
Figure 39: United States In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 40: Uniited States In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 41: United States In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 42: United States In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 43: Canada In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 44: Canada population aged 65 and above, 2014-2018 (% of total)
Figure 45: Canada GDP , 2013-2017 (USD) (In Trillion)
Figure 46: Canada Healthcare Cost Per Capita, 2013-2017 (%)
Figure 47: Canada Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
Figure 48: Canada In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 49: Canada In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 50: Canada In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 51: Canada In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 52: Rest of North America In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 53: Rest of North America In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 54: Rest of North America In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 55: Rest of North America In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 56: Rest of North America In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 57: Latin America in Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 58: Latin America population aged 65 and above, 2013-2018 (% of total)
Figure 59: Latin America GDP, 2013-2017 (USD)(In Trillion)
Figure 60: Latin America Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
Figure 61: Latin America In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 62: Latin America In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 63: Latin America In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 64: Latin America In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 65: Market Opportunity Chart of Latin America In Vitro Diagnostics Market - By Country, By Value (Year-2024)
Figure 66: Latin America IVD, By Country, Year 2018 & 2024
Figure 67: Brazil In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 68: Brazil population aged 65 and above, 2014-2018(%of total)
Figure 69: Brazil GDP , 2013-2017 (USD) (In Trillion)
Figure 70: Brazil Healthcare Cost Per Capita, 2013-2016(%)(Expected)
Figure 71: Brazil Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
Figure 72: Brazil In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 73: Brazil In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 74: Brazil In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 75: Brazil In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 76: Mexico In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 77: Mexico population aged 65 and above, 2014-2018 (% of total)
Figure 78: Mexico GDP , 2013-2017 (USD) (In Trillion)
Figure 79: Mexico Healthcare Cost Per Capita, 2013-2017 (%)
Figure 80: Mexico Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
Figure 81: Mexico In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 82: Mexico In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 83: Mexico In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 84: Mexico In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 85: Rest of Latin America In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 86: Rest of Latin America In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 87: Rest of Latin America In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 88: Rest of Latin America In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 89: Rest of Latin America In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 90: Asia Pacific in Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 91: Asia Pacific population aged 65 and above, 2014-2018 (% of total)
Figure 92: East Asia & Pacific GDP , 2013-2017 (USD) (In Trillion)
Figure 93: Asia Pacific Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
Figure 94: Asia Pacific In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 95: Asia Pacific In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 96: Asia Pacific In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 97: Asia Pacific In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 98: Market Opportunity Chart of Asia Pacific In Vitro Diagnostics Market - By Country, By Value (Year-2024)
Figure 99: Asia Pacific IVD, By Country, Year 2018 & 2024
Figure 100: Japan In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 101: Japan population aged 65 and above, 2014-2018 (% of total)
Figure 102: Japan GDP , 2013-2017 (USD) (In Trillion)
Figure 103: Japan Healthcare Cost Per Capita, 2013-2017 (%)
Figure 104: Japan Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
Figure 105: Japan In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 106: Japan In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 107: Japan In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 108: Japan In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 109: China In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 110: China population aged 65 and above, 2014-2018 (% of total)
Figure 111: China GDP, 2013-2017 (USD) (In Trillion)
Figure 112: China Healthcare Cost Per Capita, 2013-2016 (%)
Figure 113: China Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
Figure 114: China In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 115: China In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 116: China In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 117: China In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 118: India In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 119: India population aged 65 and above, 2014-2018 (% of total)
Figure 120: India GDP, 2013-2017 (USD) (In Trillion)
Figure 121: India Healthcare Cost Per Capita, 2013-2016 (%)
Figure 122: India Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
Figure 123: India In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 124: India In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 125: India In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 126: India In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 127: Rest of Asia Pacific In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 128: Rest of Asia Pacific In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 129: Rest of Asia Pacific In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 130: Rest of Asia Pacific In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 131: Rest of Asia Pacific In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 132: Europe, Middle East and Africa in Vitro Diagnostics Market Size, By Value, 2014-2024 (USD
Figure 133: European Union and North Africa Middle East population aged 65 and above, 2014-2018 (% of total)
Figure 134: European Union and North Africa Middle East,GDP , 2013-2017 (USD) (In Trillion)
Figure 135: European Union and North Africa Middle East, Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
Figure 136: EMEA In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 137: EMEA In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 138: EMEA In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 139: EMEA In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 140: Market Opportunity Chart of EMEA In Vitro Diagnostics Market - By Country, By Value (Year-2024)
Figure 141: EMEA IVD, By Country, Year 2018 & 2024
Figure 142: Germany In Vitro Diagnostic Market Size By value,2014-2024(USD Million)
Figure 143: Germany population aged 65 and above,2014-2018(% of total)
Figure 144: Germany GDP,2013-2017(USD) (In Trillion)
Figure 145: Germany Healthcare cost per capita,2014-2018(%)
Figure 146: Germany death by liver cancer, 2014-2017(per 100k individuals)
Figure 147: Germany In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 148: Germany In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 149: Germany In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 150: Germany In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 151: Italy In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 152: Italy population aged 65 and above, 2014-2018 (% of total)
Figure 153: Italy GDP, 2013-2017 (USD) (In Trillion)
Figure 154: Italy Healthcare Cost Per Capita, 2014-2018 (%)
Figure 155: Italy Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
Figure 156: Italy In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 157: Italy In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 158: Italy In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 159: Italy In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 160: UK In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 161: UK population aged 65 and above, 2014-2018 (% of total)
Figure 162: UK GDP, 2013-2017 (USD) (In Trillion)
Figure 163: UK Healthcare Cost Per Capita, 2014-2018 (%)
Figure 164: UK Death Rate by Liver Cancer, 2014-2017 (per 100K Individuals)
Figure 165: United Kingdom In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 166: UK In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 167: UK In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 168: UK In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 169: Rest of EMEA In Vitro Diagnostics Market Size, By Value, 2014-2024 (USD Million)
Figure 170: Rest of EMEA In Vitro Diagnostics Market- By Technology, By Value (USD Million), 2014-2024
Figure 171: Rest of EMEA In Vitro Diagnostics Market- By Application, By Value (USD Million), 2014-2024
Figure 172: Rest of EMEA In Vitro Diagnostics Market- By End User, By Value (USD Million), 2014-2024
Figure 173: Rest of EMEA In Vitro Diagnostics Market- By Products, By Value (USD Million), 2014-2024
Figure 174: Market Attractiveness Chart of Global In Vitro Diagnostics Market - By Technology (Year-2024)
Figure 175: Market Attractiveness Chart of Global In Vitro Diagnostics Market - By Application (Year-2024)
Figure 176: Market Attractiveness Chart of Global In Vitro Diagnostics Market - By End User(Year-2024)
Figure 177: Market Attractiveness Chart of Global In Vitro Diagnostics Market - By Products (Year-2024)
Figure 178: Market Attractiveness Chart of Global In Vitro Diagnostics Market - By Region (Year-2024)
Figure 179: Competitive Positions of In Vitro Diagnostics Companies (2018)
Figure 180: F.Hoffman-La Roche, Diagnostics Sales Revenue, 2014-2018 (USD Million)
Figure 181: F.Hoffman-La Roche, Sales Revenue, By Region, In 2018 (%)
Figure 182: F.Hoffman-La Roche Net Income, Year 2014-2018 (USD MILLION)
Figure 183: F.Hoffman-La Roche, Diagnostics Division Business Area Sales Revenue, 2018 ,(USD Million)
Figure 184: F.Hoffman-La Roche , E7 Leading Emerging Market Sales Revenue, By Region, In 2018 (%)
Figure 185: Thermo Fisher Scientific, Sales Revenue, 2014-2018 (USD Million)
Figure 186: Thermo Fisher Scientific, Net Income, 2014-2018 (USD Million)
Figure 187: Thermo Fisher Scientific, Sales Revenue, By Business Segment, In 2018 (%)
Figure 188: Thermo Fisher Scientific, Sales Revenue, By Geographical Segment, In 2018 (%)
Figure 189: Sysmex, Sales Revenue, 2014-15 to 2018-2019 (USD Million)
Figure 190: Sysmex, Net Income, 2014-2018 (USD Million)
Figure 191: Sysmex, Sales Revenue, By Geographical Segment, In 2018 (%)
Figure 192: Abbott, Total Sales Revenue, 2014-2018 (USD Million)
Figure 193: Abbott, Net Income, 2014-2018 (USD Million)
Figure 194: Abbott, Sales Revenue, By Geographical Segment, In 2018 (%)
Figure 195: Abbott, Diagnostics Sales Revenue, 2014-2018 (USD Million)
Figure 196: Abbott, Diagnostics specific Business Division Sales Revenue, , In 2018 (USD Million)
Figure 197: Danaher, Total Sales Revenue, 2014-2018 (USD Million)
Figure 198: Danaher, Net Income, 2014-2018 (USD Million)
Figure 199: Danaher, Total Sales ,By Business Segments,2018 (USD Million)
Figure 200: Danaher, Sales Revenue ,Diagnostics Segment, By Geographical Segment, In 2018 (%)
Figure 201: Siemens Healthineers , Total Sales Revenue, 2017-2018 (USD Million)
Figure 202: Siemens Healthineers, Net Income, 2017-2018 (USD Million)
Figure 203: Siemens Healthineers Sales Revenue , By Geographical Segment, In 2018 (%)
Figure 204: Siemens Healthineers , Sales Revenue, By Segments,2018 (USD Million)
Figure 205: Siemens Healthineers Revenue By Segment, In 2018 (%) (in Billion)
Figure 206: Biomerieux , Total Sales Revenue, 2014-2018 (USD Million)
Figure 207: Biomerieux, Net Income, 2014-2018 (USD Million)
Figure 208: Biomerieux Sales Revenue , By Geographical Segment, In 2018 (%)
Figure 209: Biomerieux , Sales By Application, 2018 (%)
Figure 210: Bio-Rad Laboratories Sales Revenue, 2014-2018 (USD Million)
Figure 211: Bio-Rad Laboratories ,Business Segment wise sales FY- 2016-2018 ,(USD millions)
Figure 212: Bio-Rad Laboratories Sales Revenue, By Geographic Segment (%), FY2018
Figure 213: Bio-Rad, Net Income, 2014-2018 (USD Million)
Figure 214: Becton Dickinson Sales Revenue, 2013-2014 to 2017-2018 (USD Million)
Figure 215: Becton Dickinson , Total Business Segment Revenue FY- 2018 ,(USD millions)
Figure 216: Becton Dickinson Geographic Sales Revenue,2018 (USD Million)
Figure 217: Becton Dickinson, Net Income, 2014-2018 (USD Million)
Figure 218: Becton Dickinson, Life Sciences Business Segment Revenue 2018 ,(USD millions)
List Of Table
Table A: 12. List of some FDA approved In Vitro Diagnostic Products
Table B: General IVDs for use in community settings and health facilities without laboratories
Table C: Health care facilities with clinical laboratories
Table D: Prominent In Vitro Diagnostics companies operating in North America Market
Table E: Prominent In Vitro Diagnostics companies operating in Latin America Market
Table F: Prominent In Vitro Diagnostics companies operating in Asia Pacific Market
Table G: Prominent In Vitro Diagnostics companies operating in EMEA Market
Table H: GlobalMarket share analysis of In Vitro Dignostic Companies
